COMMUNIQUÉS West-GlobeNewswire

Shockwave Receives FDA Breakthrough Device Designation for the Coronary IVL System
03/09/2019
Agency’s Breakthrough Device Designation Program Allows for Priority Review of Coronary Calcium Modification Technology SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the [...]
GeneTx and Ultragenyx Announce Orphan Drug Designation and Rare Pediatric Disease Designation for GTX-102
03/09/2019
SARASOTA, Fla. and NOVATO, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel [...]
Generex Biotechnology Confirms Record Date for 1:1 Dividend
03/09/2019
Record date of August 30, 2019 confirmed Shareholders must hold shares through October 30, 2019 to receive dividend Dividend Waived by insiders, note holders, acquisitions, and pool shares Pool shares being retired on [...]
Todos Medical Enters into MOU to Expand Existing Early Detection Breast Cancer Blood Test Distribution Partnership with Orot+ into Japan
03/09/2019
REHOVOT, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Tempus Expands Its Management Team With the Appointment of Lauren Silvis as Senior Vice President of External Affairs
03/09/2019
CHICAGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today the appointment of [...]
Recording of the Second Quarter 2019 Investor Conference Webinar
03/09/2019
On September 3 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the Chairman of Management Board Lauris Macijevskis and Investor Relations Advisor Janis Dubrovskis analyzed the [...]
Selecta Biosciences to Present at the Janney Healthcare Conference
03/09/2019
WATERTOWN, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune [...]
Cocrystal Pharma Presents Positive Preclinical Data for CC-42344 at the Options X for the Control of Influenza Conference
03/09/2019
- CC-42344 showed broad spectrum activity, excellent anti-influenza activity (EC50 <1 nM), and a strong synergistic effect with approved influenza antivirals - - Preclinical study demonstrated favorable [...]
TRACON Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference Sponsored by H.C. Wainwright
03/09/2019
SAN DIEGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Forty Seven, Inc. Granted Fast Track Designation for Magrolimab (5F9) for the Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia
03/09/2019
MENLO PARK, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced [...]
Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic with Vanderbilt University Medical Center and IDBiologics
03/09/2019
Leiden, 3 September 2019 – Today, Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery ’s GS knockout CHO K1 cell line expression system for the development of high [...]
BeiGene to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass. and BEIJING, China, Sept. 03, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Evelo Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic effects, [...]
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in September
03/09/2019
BOSTON, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity [...]
Cybrexa Therapeutics Announces Appointment of Biotech Industry Leader John Houston to Board of Directors
03/09/2019
John Houston brings more than 30 years of experience in drug discovery and development in pharma and biotech as Cybrexa prepares to transition to become a clinical-stage company NEW HAVEN, Conn., Sept. 03, 2019 (GLOBE [...]
Entasis Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
WALTHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Anchiano Therapeutics to Present at the Baird 2019 Global Healthcare Conference
03/09/2019
CAMBRIDGE, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat [...]
XOMA to Present at the H.C. Wainwright 21st Annual Global Investment Conference
03/09/2019
EMERYVILLE, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the H.C. Wainwright 21 [...]
Passage Bio to Present at Morgan Stanley 17th Annual Global Healthcare Conference
03/09/2019
PHILADELPHIA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced that [...]

Pages